Cargando…

Comprehensive investigation of oncogenic driver mutations in Chinese non-small cell lung cancer patients

PURPOSE: To determine the frequency of driver mutations in Chinese non-small cell lung cancer (NSCLC) patients. METHODS: Comprehensive mutational analysis was performed in 1356 lung adenocarcinoma, 503 squamous cell carcinoma, 57 adenosquamous lung carcinoma, 19 large cell carcinoma and 8 sarcomatoi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Rui, Zhang, Yang, Pan, Yunjian, Li, Yuan, Hu, Haichuan, Cai, Deng, Li, Hang, Ye, Ting, Luo, Xiaoyang, Zhang, Yiliang, Li, Bin, Shen, Lei, Sun, Yihua, Chen, Haiquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741453/ https://www.ncbi.nlm.nih.gov/pubmed/26486077

Ejemplares similares

Former smokers with non‐small‐cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis
por: Zheng, Shanbo, et al.
Publicado: (2016)

Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma
por: Hu, Haichuan, et al.
Publicado: (2014)

The prognostic and predictive value of solid subtype in invasive lung adenocarcinoma
por: Zhang, Yang, et al.
Publicado: (2014)

Primary concomitant EGFR T790M mutation predicted worse prognosis in non-small cell lung cancer patients
por: Li, Hang, et al.
Publicado: (2014)

ALK-Rearranged Lung Cancer in Chinese: A Comprehensive Assessment of Clinicopathology, IHC, FISH and RT-PCR
por: Li, Yuan, et al.
Publicado: (2013)

Protein expression of programmed death 1 ligand 1 and ligand 2 independently predict poor prognosis in surgically resected lung adenocarcinoma
por: Zhang, Yang, et al.
Publicado: (2014)

PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup
por: Wang, Lei, et al.
Publicado: (2014)

Comparison of clinical features, molecular alterations, and prognosis in morphological subgroups of lung invasive mucinous adenocarcinoma
por: Cai, Deng, et al.
Publicado: (2014)

EGFR Exon 18 Mutations in East Asian Patients with Lung Adenocarcinomas: A Comprehensive Investigation of Prevalence, Clinicopathologic Characteristics and Prognosis
por: Cheng, Chao, et al.
Publicado: (2015)

Sequential treatment of tyrosine kinase inhibitors and chemotherapy for EGFR-mutated non-small cell lung cancer: a meta-analysis of Phase III trials
por: Zhang, Yiliang, et al.
Publicado: (2013)

The non-small cell lung cancer EGFR extracellular domain mutation, M277E, is oncogenic and drug-sensitive
por: Yu, Su, et al.
Publicado: (2017)

Spectrum of Oncogenic Driver Mutations in Lung Adenocarcinomas from East Asian Never Smokers
por: Li, Chenguang, et al.
Publicado: (2011)

The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations
por: Zheng, Difan, et al.
Publicado: (2016)

Clinical and genetic features of lung squamous cell cancer in never-smokers
por: Huang, Yangle, et al.
Publicado: (2016)

Integrative Proteomics and Tissue Microarray Profiling Indicate the Association between Overexpressed Serum Proteins and Non-Small Cell Lung Cancer
por: Liu, Yansheng, et al.
Publicado: (2012)

The pemetrexed-containing treatments in the non-small cell lung cancer, is -/low thymidylate synthase expression better than +/high thymidylate synthase expression: a meta-analysis
por: Wang, Lei, et al.
Publicado: (2014)

Concomitant Pathogenic Mutations and Fusions of Driver Oncogenes in Tumors
por: Zhang, Runjiao, et al.
Publicado: (2021)

Comprehensive analysis of targetable oncogenic mutations in chinese cervical cancers
por: Xiang, Libing, et al.
Publicado: (2014)

Oncogene mutational analysis in Chinese gastrointestinal stromal tumor patients
por: Chen, Qiong, et al.
Publicado: (2018)

Clinical Significance of Complex Glandular Patterns in Lung Adenocarcinoma: Clinicopathologic and Molecular Study in a Large Series of Cases
por: Kuang, Muyu, et al.
Publicado: (2018)

Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis
por: Zhao, Yue, et al.
Publicado: (2016)

Oncogenic driver mutations in lung cancer
por: Luo, Susan Y, et al.
Publicado: (2013)

MET exon 14 skipping defines a unique molecular class of non-small cell lung cancer
por: Zheng, Difan, et al.
Publicado: (2016)

SOX2 expression is associated with FGFR fusion genes and predicts favorable outcome in lung squamous cell carcinomas
por: Zheng, Shanbo, et al.
Publicado: (2015)

A comprehensive study on the oncogenic mutation and molecular pathology in Chinese lung adenocarcinoma patients
por: Zhang, Xilin, et al.
Publicado: (2020)

Machine learning to predict occult metastatic lymph nodes along the recurrent laryngeal nerves in thoracic esophageal squamous cell carcinoma
por: Zhang, Yiliang, et al.
Publicado: (2023)

Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma
por: Wu, Zhigang, et al.
Publicado: (2021)

Oncogenic drivers and mitochondrial dependency
por: Alvarez-Calderon, Francesca, et al.
Publicado: (2015)

The Value of Radiotherapy for Advanced Non-Small Cell Lung Cancer With Oncogene Driver-Mutation
por: Cui, Jinfeng, et al.
Publicado: (2022)

Whole Exome Sequencing Identifies Frequent Somatic Mutations in Cell-Cell Adhesion Genes in Chinese Patients with Lung Squamous Cell Carcinoma
por: Li, Chenguang, et al.
Publicado: (2015)

Leveraging protein quaternary structure to identify oncogenic driver mutations
por: Ryslik, Gregory A., et al.
Publicado: (2016)

Clinical relevance of oncogenic driver mutations identified in endometrial carcinoma
por: Watanabe, Takafumi, et al.
Publicado: (2021)

Protein regulator of cytokinesis 1: a potential oncogenic driver
por: Li, Sijing, et al.
Publicado: (2023)

The role of B3GNT3 as an oncogene in the growth, invasion and migration of esophageal cancer cells
por: Lu, Jiaju, et al.
Publicado: (2023)

Recent Progress in Rare Oncogenic Drivers and Targeted Therapy For Non-Small Cell Lung Cancer
por: Guo, Yijia, et al.
Publicado: (2019)

Oncogenic GNAQ and GNA11 Mutations in Uveal Melanoma in Chinese
por: Xu, Xiaolin, et al.
Publicado: (2014)

Comprehensive analysis of mutational profile and prognostic significance of complex glandular pattern in lung adenocarcinoma
por: Bai, Jinsong, et al.
Publicado: (2022)

Real-World Evidence of Diagnostic Testing for Driver Oncogene Mutations in Lung Cancer in Japan
por: Yatabe, Yasushi, et al.
Publicado: (2020)

Understanding oncogenicity of cancer driver genes and mutations in the cancer genomics era
por: Porta‐Pardo, Eduard, et al.
Publicado: (2020)

Fundamental immune–oncogenicity trade-offs define driver mutation fitness
por: Hoyos, David, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1e8tj5m7m0qnp0qsn0viano1id